April 1, 2013 /PRNewswire/ -- Below are experts from the
ProfNet network that are available to discuss timely issues in your coverage area. If you are interested in interviewing any of the experts, please contact them via the contact information at the end of the listing.
If you are in need of additional experts, you can also
submit a query to the hundreds of thousands of experts in our network. You can filter your request by institution type and geographic location to get the most targeted responses. The best part? It's free! Just fill out the
query form to get started.
If you have any questions or need assistance with any aspect of ProfNet, please drop us a note at
- Clean Energy Manufacturing Initiative
- Big Data and Cancer Care
- Treatment Algorithms and Cancer Care
- Senior Investment Writer – Kiplinger's Personal Finance (DC)
- Associate Editor – I-5 Publishing (KY)
- Business Reporter – Seattle Times
OTHER NEWS & RESOURCES
- Upcoming PR/Media Events
- Creating a Great Journalism Portfolio
- Blog Notes: Design, Lifestyle, Travel & Medicine
Clean Energy Manufacturing Initiative
PresidentInformation Technology and Innovation Foundation"The Department of Energy has been at the forefront of research and development in next-generation clean energy technologies. The Clean Energy Manufacturing Initiative helps support a robust energy manufacturing sector that can produce emerging clean energy technologies, spur innovation, and boost economic growth."Atkinson is co-author of "Innovation Economics: The Race for Global Advantage." He was also appointed by President Obama to serve on the National Innovation and Competitiveness Strategy Advisory Board. He is based in
Big Data and Cancer Care
, M.D., M.S.Chief Medical Information OfficerMD Anderson"With the technological facility to marry genomic and other patient data, we now have the potential to generate scientifically based information on the best treatment option for a patient in mere minutes. The rules of cancer are in the genome. Big data provides cancer researchers and oncologists a key to unlock the rulebook."Frenzel is the first-ever chief medical information officer of MD Anderson, appointed to the newly created position this past June. As CMIO, he oversees the clinical information technology areas, including EHR development, implementation, and support; clinical applications and support; and clinical analytics and informatics. Frenzel is a professor of anesthesiology and perioperative medicine at MD Anderson and an adjunct professor of biomedical information, spending one day each week in the operating room. He is a co-leader on the effort to merge clinical, pharmacy and genomics databases onto a big data platform at MD Anderson as part of the institution's Moonshot Program. He is available discuss the emerging field of big data in relation to its use in cancer care.Bio:
Treatment Algorithms and Cancer Care
, Ph.D.Cancer Geneticist, Professor of Genomic MedicineMD Anderson"One of the biggest challenges big data presents, but also an area we're eagerly anticipating, is the ability to distill this data down to its essence, draw out the key relationships and begin to form treatment algorithms. Once tested, such algorithms can help direct the standard of care in the community."As a co-leader on the Moonshots Program, Futreal is charged with directing the design and implementation of MD Anderson's big data platform. Prior to joining MD Anderson, Futreal was the joint director of the Cancer Genome Project at the Wellcome Trust Sanger Institute. A true left brain-right brain prodigy who records acoustic guitar compilations in his free time, Futreal brings the ability to visualize large-scale data systems, making them accessible, intuitive, and valuable to cancer researchers and clinicians. His research has explored the human cancer genome, focusing on BRCA1 and BRCA2 in breast cancer and BRAF in melanoma. He is available discuss the emerging field of big data in relation to its use in cancer care.Bio:
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts